BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 31534521)

  • 21. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
    Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
    Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. OV6⁺ tumor-initiating cells contribute to tumor progression and invasion in human hepatocellular carcinoma.
    Yang W; Wang C; Lin Y; Liu Q; Yu LX; Tang L; Yan HX; Fu J; Chen Y; Zhang HL; Tang L; Zheng LY; He YQ; Li YQ; Wu FQ; Zou SS; Li Z; Wu MC; Feng GS; Wang HY
    J Hepatol; 2012 Sep; 57(3):613-20. PubMed ID: 22612999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CXCL12/CXCR4 promotes proliferation, migration, and invasion of adamantinomatous craniopharyngiomas via PI3K/AKT signal pathway.
    Yin X; Liu Z; Zhu P; Wang Y; Ren Q; Chen H; Xu J
    J Cell Biochem; 2019 Jun; 120(6):9724-9736. PubMed ID: 30582214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
    Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J
    J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roles of chemokine receptor 4 (CXCR4) and chemokine ligand 12 (CXCL12) in metastasis of hepatocellular carcinoma cells.
    Liu H; Pan Z; Li A; Fu S; Lei Y; Sun H; Wu M; Zhou W
    Cell Mol Immunol; 2008 Oct; 5(5):373-8. PubMed ID: 18954561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NR2F1 contributes to cancer cell dormancy, invasion and metastasis of salivary adenoid cystic carcinoma by activating CXCL12/CXCR4 pathway.
    Gao XL; Zheng M; Wang HF; Dai LL; Yu XH; Yang X; Pang X; Li L; Zhang M; Wang SS; Wu JB; Tang YJ; Liang XH; Tang YL
    BMC Cancer; 2019 Jul; 19(1):743. PubMed ID: 31357956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of zinc finger protein 384 (ZNF 384), a poor prognostic predictor, promotes cell growth by upregulating the expression of Cyclin D1 in Hepatocellular carcinoma.
    He L; Fan X; Li Y; Chen M; Cui B; Chen G; Dai Y; Zhou D; Hu X; Lin H
    Cell Death Dis; 2019 Jun; 10(6):444. PubMed ID: 31168049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional expression of CXCL12/CXCR4 in liver and hepatocellular carcinoma and cell-cycle variation during in vitro differentiation.
    Shibuta K; Mori M; Shimoda K; Inoue H; Mitra P; Barnard GF
    Jpn J Cancer Res; 2002 Jul; 93(7):789-97. PubMed ID: 12149145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib.
    Zheng N; Liu W; Li B; Nie H; Liu J; Cheng Y; Wang J; Dong H; Jia L
    J Exp Clin Cancer Res; 2019 May; 38(1):232. PubMed ID: 31151472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular CXCR4 Expression Promotes Vessel Sprouting and Sensitivity to Sorafenib Treatment in Hepatocellular Carcinoma.
    Xu J; Liang J; Meng YM; Yan J; Yu XJ; Liu CQ; Xu L; Zhuang SM; Zheng L
    Clin Cancer Res; 2017 Aug; 23(15):4482-4492. PubMed ID: 28223275
    [No Abstract]   [Full Text] [Related]  

  • 32. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4.
    Yi L; Zhou X; Li T; Liu P; Hai L; Tong L; Ma H; Tao Z; Xie Y; Zhang C; Yu S; Yang X
    J Exp Clin Cancer Res; 2019 Aug; 38(1):339. PubMed ID: 31382985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HMGA1B/2 transcriptionally activated-POU1F1 facilitates gastric carcinoma metastasis via CXCL12/CXCR4 axis-mediated macrophage polarization.
    Tang C; Lei X; Xiong L; Hu Z; Tang B
    Cell Death Dis; 2021 Apr; 12(5):422. PubMed ID: 33927188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exosome-mediated secretion of LOXL4 promotes hepatocellular carcinoma cell invasion and metastasis.
    Li R; Wang Y; Zhang X; Feng M; Ma J; Li J; Yang X; Fang F; Xia Q; Zhang Z; Shang M; Jiang S
    Mol Cancer; 2019 Jan; 18(1):18. PubMed ID: 30704479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emodin suppresses migration and invasion through the modulation of CXCR4 expression in an orthotopic model of human hepatocellular carcinoma.
    Manu KA; Shanmugam MK; Ong TH; Subramaniam A; Siveen KS; Perumal E; Samy RP; Bist P; Lim LH; Kumar AP; Hui KM; Sethi G
    PLoS One; 2013; 8(3):e57015. PubMed ID: 23472074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. circZFR promotes cell proliferation and migration by regulating miR-511/AKT1 axis in hepatocellular carcinoma.
    Yang X; Liu L; Zou H; Zheng YW; Wang KP
    Dig Liver Dis; 2019 Oct; 51(10):1446-1455. PubMed ID: 31147216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target.
    Chen H; Wong CC; Liu D; Go MYY; Wu B; Peng S; Kuang M; Wong N; Yu J
    Theranostics; 2019; 9(18):5246-5260. PubMed ID: 31410213
    [No Abstract]   [Full Text] [Related]  

  • 39. MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence.
    Liu M; Hu Q; Tu M; Wang X; Yang Z; Yang G; Luo R
    J Exp Clin Cancer Res; 2018 Jan; 37(1):10. PubMed ID: 29357919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FAM134B induces tumorigenesis and epithelial-to-mesenchymal transition via Akt signaling in hepatocellular carcinoma.
    Zhang ZQ; Chen J; Huang WQ; Ning D; Liu QM; Wang C; Zhang L; Ren L; Chu L; Liang HF; Fan HN; Zhang BX; Chen XP
    Mol Oncol; 2019 Apr; 13(4):792-810. PubMed ID: 30556279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.